Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
In late 2025, the conversation has shifted from Should we cover them? to How do we survive covering them? A new market trend report from the Peterson Health Technology Institute (PHTI), Employer Approaches to GLP-1 Coverage , offers a standardized framework for this new reality
P., Thompson, T
Doesnt work that way
OKAVA Pharmaceuticals, the San Francisco-based manufacturer of the medication, said the landmark clinical study of the "first-in-class" device could have "profound" implications for diabetes, kidney disease, healthy aging and longevity in pets
US$ 22.97
US$ 26.40
US$ 25.68
